Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies (PSM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02073500|
Recruitment Status : Recruiting
First Posted : February 27, 2014
Last Update Posted : October 15, 2015
|Condition or disease||Intervention/treatment|
|Pseudomyxoma Peritonei. Colorectal Carcinoma. Ovarian Carcinoma. Mesothelioma.||Other: Observational study.|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||200 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Prospective Observational Study of Peritoneal Surface Malignancies (PSM) - Characterization, Models and Treatment Strategies.|
|Study Start Date :||September 2009|
|Estimated Primary Completion Date :||January 2017|
|Estimated Study Completion Date :||January 2023|
Patients diagnosed with PSM undergoing CRS with HIPEC.
Other: Observational study.
Analysis of metastatic tissue and blood specimens collected from patients with PSM undergoing CRS-HIPEC. CRS: Removal of all macroscopically detectable tumor.
HIPEC: Instillation of heated chemotherapy in the abdominal cavity to remove residual cancer disease.
Other Name: Observational study. Laboratory biomarker analysis.
- Overall survival (OS) [ Time Frame: 5 years ]
- Progression-free survival (PFS) [ Time Frame: 5 years ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02073500
|Contact: Kjersti Flatmark, MD PhD||+47 22 78 18 73||Kjersti.Flatmark@rr-research.no|
|Contact: Annette Torgunrud Kristensen, PhD||+47 22 78 23 email@example.com|
|The Norwegian Radium Hospital||Recruiting|
|Contact: Kjersti Flatmark, MD PhD +47 22 78 18 73 Kjersti.Flatmark@rr-research.no|
|Contact: Annette Torgunrud Kristensen, PhD +47 22 78 23 12 firstname.lastname@example.org|
|Principal Investigator: Kjersti Flatmark, MD PhD|
|Principal Investigator:||Kjersti Flatmark, MD PhD||Oslo University Hospital|